BBNX

Beta Bionics Stock Analysis

AI Rating

Fair
  • Quality2/10
  • Growth↑ 5/10
  • Momentum↓ 1/10
Beta Bionics sales and earnings growth
BBNX Growth
Neutral
  • Revenue Y/Y↑ 67.01%
  • EPS Y/Y↑ 52.44%
  • FCF Y/Y↓ -39.35%
Beta Bionics gross and profit margin trends
BBNX Profitability
Neutral
  • Gross margin ↑ 54.50%
  • EPS margin↓ -87.90%
  • ROIC↓ -32.90%
Beta Bionics net debt vs free cash flow
BBNX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -38922.0

Beta Bionics stock volatility is higher than the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗